Design (Testphase)
Momentum & Trend
Stan Weinstein: Stage 2
10
Hits
July 15, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 10 hits from US
Weinstein Stage 2 — uptrend: the price is above the rising 30-week line. This is the markup phase and the only one in which Weinstein goes long. Cleanly calculated from price history (150-day SMA + slope).
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Long / Short
- Long = betting on rising prices (buying the stock). Short = betting on falling prices (selling borrowed shares to buy them back cheaper later). Our short scanners are warning or watch lists - not buy candidates.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- SMA / Moving Average (10-, 20-, 50-, 200-Day Line)
- The average price of the last X days, plotted as a line on the chart (Simple Moving Average). The 50-day and 200-day lines are the most closely watched: price above the line = uptrend intact. The 30-week line from the Weinstein method corresponds to the 150-day line.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RIOT Riot Platforms, Inc. | 07/30 | — | — | Stage 2 | D -36 | 2 von 9 | 10.6 | Capital Markets | – | — | Financial Services | 20.20 $ | +126.4 % | — | — | — | — | 95 | 74 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 3.1 | 81.6 % | — | — | |
| RCUS Arcus Biosciences Inc | 08/05 | — | — | Stage 2 | D -33 | 0 von 9 | 3.8 | Biotechnology | – | — | Healthcare | 28.30 $ | +18.3 % | — | — | — | — | 93 | 42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.0 | 72.4 % | — | — | |
| TSHA Taysha Gene Therapies Inc | 08/11 | — | — | Stage 2 | D -29 | 4 von 9 | 0.0 | Biotechnology | – | — | Healthcare | 5.70 $ | +24.7 % | — | — | — | — | 93 | 50 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.4 | 95.8 % | — | — | |
| SEI Solaris Energy Infrastructure, Inc | 07/22 | — | — | Stage 2 | B +48 | 5 von 9 | 7.8 | Oil & Gas Equipment & Servic | – | — | Energy | 69.50 $ | +70.3 % | — | — | — | — | 92 | 87 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.1 | 113.1 % | — | — | |
| TGTX TG Therapeutics Inc | 08/03 | — | — | Stage 2 | B +37 | 5 von 9 | 8.3 | Biotechnology | – | — | Healthcare | 54.90 $ | +80.9 % | — | — | — | — | 90 | 92 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 6.2 | 70.2 % | — | — | |
| CYTK Cytokinetics Inc | 08/06 | — | — | Stage 2 | D -21 | 3 von 9 | 10.9 | Biotechnology | – | — | Healthcare | 81.90 $ | +25.9 % | — | — | — | — | 88 | 42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -7.3 | 118.8 % | — | — | |
| SHLS Shoals Technologies Group Inc | 08/04 | — | — | Stage 2 | B +17 | 2 von 9 | 1.8 | Solar | – | — | Technology | 10.80 $ | +20.9 % | — | — | — | — | 87 | 66 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 6.6 | 121.3 % | — | — | |
| MSGE Madison Square Garden Entertainmen | 08/12 | — | — | Stage 2 | B +15 | 6 von 9 | 3.7 | Entertainment | – | — | Communication Services | 73.70 $ | +41.8 % | — | — | — | — | 86 | 18 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.1 | 102.1 % | — | — | |
| EXEL Exelixis Inc | 07/27 | — | — | Stage 2 | B +46 | 8 von 9 | 13.4 | Biotechnology | – | — | Healthcare | 55.80 $ | +17.1 % | — | — | — | — | 69 | 76 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 10.7 | 107.5 % | — | — | |
| KEX Kirby Corporation | 07/30 | — | — | Stage 2 | B +19 | 6 von 9 | 7.4 | Marine Shipping | – | — | Industrials | 145.00 $ | +25.5 % | — | — | — | — | 68 | 60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 103.0 % | — | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Weinstein Stage 2 — uptrend: the price is above the rising 30-week line. This is the markup phase and the only one in which Weinstein goes long. Cleanly calculated from price history (150-day SMA + slope).
All scanners are recalculated daily across the entire stock universe — most recently on 15. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 10 stocks pass this scanner's criteria (as of 15. July 2026).
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- 21-EMA Trend
- Above 21-EMA Pullback
- Above the 50- & 200-SMA
- Ameet Rai: Daily Liquidity
- Character Change (CC)
- Gary Antonacci: Dual Momentum (Stock Adaptation)
- High ADR (≥5%)
- Jeff Sun
- Kathy Donnelly: Liquid Movers Up
- Mark Minervini: Trend Criteria — 1 Month
- Mike Webster: Swing Trading List
- Near 52-Week High
- Oliver Kell: Doublers
- Oliver Kell: Strength on Down Day
- Power Trend
- Qullamaggie: Top Gainers 6M
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- RS New Highs
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Checklist
- Stan Weinstein: Stage 3
- Strength on Stress Days
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.